Midazolam: Safety of use in palliative care: A systematic critical review

ConclusionMidazolam is one of three most frequently administered drugs in palliative care. The indications for its use include anxiety, dyspnea, seizures, vomiting refractory to treatment, agitation, myoclonus, status epilepticus, restlessness, delirium, pruritus, hiccups, insomnia, analgosedation, palliative sedation and preventing or counteracting undesired effects of ketamine.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research